Novartis Pharmaceuticals

About Novartis Pharmaceuticals

Novartis Pharmaceuticals is a global healthcare company based in the UK, dedicated to reimagining medicine to improve and extend people’s lives. With a strong commitment to innovation, Novartis focuses on developing breakthrough treatments that address unmet medical needs across various therapeutic areas.

The company operates through two main divisions: Innovative Medicines and Sandoz. The Innovative Medicines division is responsible for the research, development, and marketing of patented pharmaceuticals, while Sandoz specializes in generic and biosimilar medicines, ensuring access to high-quality healthcare for patients worldwide.

Novartis invests heavily in research and development, with a significant portion of its revenue allocated to discovering new therapies and improving existing ones. The company collaborates with academic institutions, biotechnology firms, and other pharmaceutical companies to foster innovation and accelerate the development of new treatments.

In addition to its focus on innovative therapies, Novartis is committed to sustainability and corporate responsibility. The company strives to minimize its environmental impact and enhance access to healthcare in underserved communities.

With a diverse portfolio of products, Novartis addresses a wide range of health conditions, including cardiovascular diseases, oncology, immunology, and neuroscience. The company’s mission is to provide solutions that improve patient outcomes and enhance the quality of life.

Novartis is also dedicated to fostering a culture of inclusion and diversity within its workforce, recognizing that a diverse team drives creativity and innovation. The company believes in empowering its employees and providing them with opportunities for professional growth and development.

As a leader in the pharmaceutical industry, Novartis continues to push the boundaries of science and technology, aiming to transform the future of healthcare.